Simon C. Ling
The Hospital for Sick Children, The University of Toronto
Mandana Khalili
University of California, San Francisco
Bonnie Burgess-Beusse
National Institute of Health, NIH
Hersh Shroff
UNC Chapel Hill
Adam Winters
Icahn School of Medicine at Mount Sinai
Alexander Vogel
Recanati/Miller Transplantation Institute at Mount Sinai
Edward Doo
Niddk, Nih, Liver Diseases Branch
Manal El-Sayed
Ain Shams University
Controlled Human Infection Model for HCV Vaccine Trials: Has the time come?
Despite the development of remarkably effective direct-acting antivirals, with the ongoing opioid epidemic and continued unsafe medical practices globally, new hepatitis C virus (HCV) infections continue to outpace cures, limiting progress towards HCV eli